Hardy, J., Haywood, A., Gogna, G., Martin, J., Yates, P., Greer, R., & Good, P. (2020). Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: A double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Current controlled trials in cardiovascular medicine, 21(1), 611-8. https://doi.org/10.1186/s13063-020-04541-6
Chicago-Zitierstil (17. Ausg.)Hardy, Janet, Alison Haywood, Gauri Gogna, Jennifer Martin, Patsy Yates, Ristan Greer, und Phillip Good. "Oral Medicinal Cannabinoids to Relieve Symptom Burden in the Palliative Care of Patients with Advanced Cancer: A Double-blind, Placebo-controlled, Randomised Clinical Trial of Efficacy and Safety of 1:1 Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)." Current Controlled Trials in Cardiovascular Medicine 21, no. 1 (2020): 611-8. https://doi.org/10.1186/s13063-020-04541-6.
MLA-Zitierstil (9. Ausg.)Hardy, Janet, et al. "Oral Medicinal Cannabinoids to Relieve Symptom Burden in the Palliative Care of Patients with Advanced Cancer: A Double-blind, Placebo-controlled, Randomised Clinical Trial of Efficacy and Safety of 1:1 Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)." Current Controlled Trials in Cardiovascular Medicine, vol. 21, no. 1, 2020, pp. 611-8, https://doi.org/10.1186/s13063-020-04541-6.